- Home
- SUGP vs CSCI Comparison
SUGP vs CSCI Comparison
Compare SUGP & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUGP
- CSCI
- Stock Information
- Founded
- SUGP 1998
- CSCI 1990
- Country
- SUGP Hong Kong
- CSCI Canada
- Employees
- SUGP N/A
- CSCI N/A
- Industry
- SUGP
- CSCI
- Sector
- SUGP
- CSCI
- Exchange
- SUGP NYSE
- CSCI NYSE
- Market Cap
- SUGP 8.9M
- CSCI 10.5M
- IPO Year
- SUGP 2024
- CSCI 1996
- Fundamental
- Price
- SUGP $0.80
- CSCI $3.61
- Analyst Decision
- SUGP
- CSCI
- Analyst Count
- SUGP 0
- CSCI 0
- Target Price
- SUGP N/A
- CSCI N/A
- AVG Volume (30 Days)
- SUGP 30.6K
- CSCI 3.3K
- Earning Date
- SUGP 07-21-2025
- CSCI 05-13-2025
- Dividend Yield
- SUGP N/A
- CSCI N/A
- EPS Growth
- SUGP 1.19
- CSCI N/A
- EPS
- SUGP 0.11
- CSCI N/A
- Revenue
- SUGP $23,446,259.00
- CSCI $9,030,000.00
- Revenue This Year
- SUGP N/A
- CSCI N/A
- Revenue Next Year
- SUGP N/A
- CSCI N/A
- P/E Ratio
- SUGP $7.62
- CSCI N/A
- Revenue Growth
- SUGP 11.29
- CSCI 36.51
- 52 Week Low
- SUGP $0.52
- CSCI $1.96
- 52 Week High
- SUGP $3.25
- CSCI $7.72
- Technical
- Relative Strength Index (RSI)
- SUGP 49.03
- CSCI N/A
- Support Level
- SUGP $0.76
- CSCI N/A
- Resistance Level
- SUGP $0.86
- CSCI N/A
- Average True Range (ATR)
- SUGP 0.08
- CSCI 0.00
- MACD
- SUGP -0.02
- CSCI 0.00
- Stochastic Oscillator
- SUGP 14.71
- CSCI 0.00
About SUGP SU GROUP HLDGS LTD
SU Group Holdings Ltd and its subsidiaries is an integrated security-related services company. The company has two reportable segments: security-related engineering services, and security guarding and screening services and related vocational training services. The company generates the majority of its revenue from the security-related engineering services segment. Geographically operates in Hong Kong, and Other foreign countries, with maximum revenue from Kong Kong.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.